FEMSelect announced positive results from a four-year prospective follow-up evaluation of its EnPlace system. Newark, Delaware-based FEMSelect designed its EnPlace system as a minimally invasive, meshless approach to pelvic floor ligament fixation. The device attaches sutures to ligaments of the pelvic floor. It represents an alternative to heavily scrutinized pelvic mesh devices. Medical investigators found […]
FEMSelect
FemSelect closes enrollment for mesh-free pelvic floor device study
FemSelect yesterday said it closed enrollment in the EnPlace post-market study of its mesh-free pelvic floor repair device. The Tel Aviv, Israel-based company enrolled 60 female patients aged 36 to 84 years at 15 sites in the U.S., Germany and Israel for the global, two-phase study. The observational study will assess the long-term safety, durability […]